Presentations & Publications
Explore scientific presentations and publications about our investigational programs.
October 2022 Poster
SLEuro
A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus: optimization of a lupus clinical trial design
October 2022 Poster
SLEuro
Afimetoran, a potent and selective inhibitor of human Toll-like receptor 7 (TLR 7) and TLR 8, provides robust efficacy in a murine lupus model of advanced disease
August 2022 Poster
ACS Fall Symposium
Identification of 2-pyridinyl-indoles as selective dual antagonists of the toll-like receptors 7 and 8 (TLR7/8) for the treatment of autoimmune diseases
August 2022 Presentation
ACS Fall Symposium
Exploration of carbazole-based antagonists of toll-like receptors 7 and 8 (TLR7/8) generated via structure-guided evolution of an indole series
August 2022 Presentation
ACS Fall Symposium
Discovery of afimetoran, a small molecule dual antagonist of the toll-like receptors 7 and 8 (TLR7/8) advanced to clinical evaluation in patients with lupus
March 2022 Poster
ACS National Meeting
Optimization of 4H-pyrrolo[3,2-d]thiazolebasedantagonists of toll-like receptors 7 and 8 (TLR7/8) for the treatment of lupus
On this page you may select links to key publications from peer-reviewed journals as well as to materials presented at scientific conferences relating to either research studies involving Beeline’s investigational product candidates or to the science guiding our research and development efforts. The safety and efficacy of any investigational product discussed in these materials has yet to be determined. Note that certain of these materials were authored by unaffiliated third parties and do not represent Beeline’s views. The content of each work is the property of the respective copyright holder and may not be further distributed without their express permission. The information in these materials may not be current or comprehensive, and Beeline undertakes no obligation to correct or update such information.
